TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
03/01/2023
Voltar para busca
Dado oficial do USPTO
HANCHORBIO
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
HANCHORBIO
ST13
US500000090772551Classe
5, 35, 42
Pedido
90772551
Registro
6824471
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
22
Atualização mais recente
03/01/2023
Tipo de marca
Verbal
Classes Nice
5, 35, 42
Data de depósito
14/06/2021
Data de registro
23/08/2022
Data de expiração
-
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
23/08/2022
Última transação
23/08/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use, Foreign priority
Código do desenho
4
Tipo de titular
16
Localização do titular
Taipei City, TW
Examinador
KUYKENDALL, LYNDSEY
Unidade examinadora
N60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
HanchorBio Inc.
Representantes
Joe McKinney Muncy MUNCY, GEISSLER, OLDS & LOWE, P.C.
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical products and medicines for the treatment of cancers or autoimmune diseases for human use; Reagents for medical diagnostics; Therapeutic reagents for promoting hair growth; Vaccines for human use; Pharmaceutical reagents for medical useto enhance immunity; Anti-cancer reagents and medicines; Image-forming reagents for medical diagnostics; Western medicines for treating cancers or autoimmune diseases; Chinese medicines for treating cancers or autoimmune diseases; Anti-viral reagents and medicines for treating cancers or autoimmune diseases; Biological reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Protein reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Chemical reagents and medicines for medical therapeutic use for the treatment of cancers or autoimmune diseases; Biological tissue culture reagents for medical therapeutic use for the treatment of cancers or autoimmune diseases; Testing chemicals for medical therapeutic use for the treatment of cancers or autoimmune diseases; Diagnostic reagents for medical therapeutic use; Biomarker diagnostic reagents for medical therapeutic use; Nutritional supplements; Biological reagents for veterinary use
Classe 35
retail and wholesale store services featuring pharmaceutical products; retail and wholesale store services featuring western medicines; retail and wholesale store services featuring Chinese medicines; retail and wholesale store services featuring nutritional supplements; retail and wholesale store services featuring medical equipment
Classe 42
Providing services for biomedical research and developmentproducing biological medicines; Biological research; Bacteriological research; Providing experimental medicines sample testing and diagnostic services for others for clinical research purposes; Providing reagent sample testing and diagnostic services for others for clinical research purposes; Clinical testing of pharmaceutical medicines for others; Scientific research and analysis of experimental medicines or reagents; Medical research; Product research and development on behalf of other parties; Technical research in the field of pharmaceutical studies; Research for technological programs in the nature of biological drug design; Technical writingwriting of technological documents; industrial analysis and research services; Rental of laboratory equipment for experiments; Service for scientific laboratories; Scientific research; Technological consultancy in the field of biological protein engineering; Scientific research in the field of biological/biomedical protein design and engineering; technical research in the field of biological/biomedical protein design and engineering
Publicações
Histórico de despachos e eventos da marca no USPTO.
22 publicações encontradas
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
03/01/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
03/01/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
03/01/2023
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
23/08/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
23/08/2022
ISPO
WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
14/06/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
08/06/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/06/2022
PUBO
PUBLISHED FOR OPPOSITION
07/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/05/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/05/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/04/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/04/2022
ALIE
ASSIGNED TO LIE
04/04/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/03/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/03/2022
GNRT
NON-FINAL ACTION E-MAILED
08/03/2022
CNRT
NON-FINAL ACTION WRITTEN
08/03/2022
DOCK
ASSIGNED TO EXAMINER
03/03/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/09/2021
NWAP
NEW APPLICATION ENTERED
17/06/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HANCHORBIO ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.